Literature DB >> 19531026

The role of fibroblast growth factor 21 (FGF21) on energy balance, glucose and lipid metabolism.

Daniel Cuevas-Ramos1, Paloma Almeda-Valdes, Carlos A Aguilar-Salinas, Gabriel Cuevas-Ramos, Andres A Cuevas-Sosa, Francisco J Gomez-Perez.   

Abstract

FGF21 is a novel member of the FGFs family, is mainly expressed in liver and it functions as a potent activator of glucose uptake on adipocytes. When over expressed in transgenic mice, it protects animals from diet-induced obesity and its administration to diabetic rodents and monkeys lowers blood glucose and triglyceride levels. Recently, increased levels of FGF21 have been identified as an independent risk factor related with metabolic syndrome. A review of the relevant roles of FGF21 in metabolism is presented here.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19531026     DOI: 10.2174/157339909789804396

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  20 in total

1.  Role of histone deacetylase 9 in regulating adipogenic differentiation and high fat diet-induced metabolic disease.

Authors:  Tapan K Chatterjee; Joshua E Basford; Kan Hui Yiew; David W Stepp; David Y Hui; Neal L Weintraub
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

2.  Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway.

Authors:  Chi Zhang; Zhifeng Huang; Junlian Gu; Xiaoqing Yan; Xuemian Lu; Shanshan Zhou; Shudong Wang; Minglong Shao; Fangfang Zhang; Peng Cheng; Wenke Feng; Yi Tan; Xiaokun Li
Journal:  Diabetologia       Date:  2015-06-04       Impact factor: 10.122

3.  Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis.

Authors:  Srinivasan Dasarathy; Yu Yang; Arthur J McCullough; Susan Marczewski; Carole Bennett; Satish C Kalhan
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-05       Impact factor: 2.566

4.  Transcriptional repressor E4-binding protein 4 (E4BP4) regulates metabolic hormone fibroblast growth factor 21 (FGF21) during circadian cycles and feeding.

Authors:  Xin Tong; Marina Muchnik; Zheng Chen; Manish Patel; Nan Wu; Shree Joshi; Liangyou Rui; Mitchell A Lazar; Lei Yin
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

5.  Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes.

Authors:  Wei Chen; Ruby Lai-chong Hoo; Morichika Konishi; Nobuyuki Itoh; Pui-Chi Lee; Hong-ying Ye; Karen Siu-ling Lam; Aimin Xu
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

6.  Transcriptional profiling reveals a role for RORalpha in regulating gene expression in obesity-associated inflammation and hepatic steatosis.

Authors:  Hong Soon Kang; Kyoko Okamoto; Yukimasa Takeda; Ju Youn Beak; Kevin Gerrish; Carl D Bortner; Laura M DeGraff; Taira Wada; Wen Xie; Anton M Jetten
Journal:  Physiol Genomics       Date:  2011-05-03       Impact factor: 3.107

7.  Targeting energy expenditure via fuel switching and beyond.

Authors:  J G Geisler
Journal:  Diabetologia       Date:  2010-10-17       Impact factor: 10.122

Review 8.  Impact of acute exercise on immediate and following early post-exercise FGF-21 concentration in adults: systematic review and meta-analysis.

Authors:  Mousa Khalafi; Karim Azali Alamdari; Michael E Symonds; Hadi Nobari; Jorge Carlos-Vivas
Journal:  Hormones (Athens)       Date:  2020-11-05       Impact factor: 2.885

Review 9.  Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases.

Authors:  Fangfang Zhang; Lechu Yu; Xiufei Lin; Peng Cheng; Luqing He; Xiaokun Li; Xuemian Lu; Yi Tan; Hong Yang; Lu Cai; Chi Zhang
Journal:  Mol Endocrinol       Date:  2015-08-26

10.  The effects of exercise training associated with low-level laser therapy on biomarkers of adipose tissue transdifferentiation in obese women.

Authors:  Raquel Munhoz da Silveira Campos; Ana Raimunda Dâmaso; Deborah Cristina Landi Masquio; Fernanda Oliveira Duarte; Marcela Sene-Fiorese; Antonio Eduardo Aquino; Filippo Aragão Savioli; Pamela Cristina Lopes Quintiliano; Ana Claudia Pelissari Kravchychyn; Liliane Isabel Guimarães; Lian Tock; Lila Missae Oyama; Valter Tadeu Boldarine; Vanderlei Salvador Bagnato; Nivaldo Antonio Parizotto
Journal:  Lasers Med Sci       Date:  2018-02-23       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.